Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer
“Amy led the clinical and regulatory aspects for
Prior to joining Obalon, Ms. VandenBerg held positions of increasing leadership at other medical device companies, including
To the extent that statements contained in this press release are not descriptions of historical facts regarding
Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.